Tweet
Forbes (blog)
<img alt="" height="1" width="1" />
Abbott's TriCor Shows No Benefit For Diabetics In Study
Wall Street Journal
Abbott Laboratories' (ABT) cholesterol drug TriCor failed to significantly reduce the risk of heart attacks and strokes among diabetics in a large government-sponsored study, reinforcing doubts about the drug's ...
No heart benefit seen with fibrates in diabeticsReuters
Studies: Intense treatment doesn't help diabeticsBioscience Technology
Abbott's TriCor With Statin Fails to Cut Diabetic Heart RiskBusinessWeek
Forbes (blog) -Benzinga -Forbes (blog)
all 49 news articles »
More...